FDA issues lorcaserin PDUFA date

Arena Pharmaceuticals Inc. (NASDAQ:ARNA) said FDA assigned a PDUFA date of Oct. 22 for an NDA for lorcaserin for weight management. Lorcaserin is a serotonin (5-HT2C) receptor agonist. Arena was down ...